| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | -225.76 | -513.21 | -1,302.32 | 841.61 |
| Net Changein Cash | -186.40 | -207.49 | 41.62 | 57.96 |
| Cash Taxes Paid | 504.02 | 406.94 | 273.39 | 396.90 |
| Net Income/ Starting Line | 2,527.03 | 2,023.13 | 1,304.77 | 1,844.28 |
| Total Cash Dividends Paid | -504.62 | -540.49 | -529.52 | -421.91 |
| Changesin Working Capital | -717.99 | -458.63 | 53.38 | -941.86 |
| Cashfrom Operating Activities | 1,912.84 | 1,948.07 | 1,682.50 | 1,111.02 |
| Cash Interest Paid | 80.61 | 91.31 | 90.46 | 40.13 |
| Cashfrom Financing Activities | -810.99 | -1,145.01 | -1,760.82 | 379.57 |
| Depreciation/ Depletion | 357.16 | 299.30 | 310.42 | 303.96 |
| Other Investing Cash Flow Items Total | -623.14 | -749.21 | 345.75 | -1,096.25 |
| Capital Expenditures | -675.62 | -259.29 | -232.91 | -338.88 |
| period Type | - | - | - | - |
| Foreign Exchange Effects | 10.51 | -2.05 | 7.10 | 2.50 |
| Non- Cash Items | -253.36 | 84.27 | 13.93 | -95.36 |
| Financing Cash Flow Items | -80.61 | -91.31 | -90.46 | -40.13 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -1,298.76 | -1,008.50 | 112.84 | -1,435.13 |
| Issuance( Retirement)of Stock Net | - | - | 161.48 | - |
Alkem Laboratories Dividend Alkem Laboratories Bonus Alkem Laboratories News Alkem Laboratories AGM Alkem Laboratories Rights Alkem Laboratories Splits Alkem Laboratories Board Meetings Alkem Laboratories Key Metrics Alkem Laboratories Shareholdings Alkem Laboratories Profit Loss Alkem Laboratories Balance Sheet Alkem Laboratories Q1 Results Alkem Laboratories Q2 Results Alkem Laboratories Q3 Results Alkem Laboratories Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks